ATS 2019 Virtual Final Program

915 Development and Characterization of Reporter Mice for Canonical Transforming Growth Factor (TGF)-ß Signaling/ F. Palumbo, T. Likhoshvay, M. Gunjak, W. Seeger, R.E. Morty, Bad Nauheim, Germany, p.A6044 916 Identifying Sex-Dependent Changes in CD4+ T Cell Phenotype and Plasma Cytokine Levels from Infants Exposed to the In Utero Inflammatory Conditions of Clinical Chorioamnionmitis/ R. Misra, H.L. Huyck, S.K. Misra, C. Kwon, A. McDavid, L. Yang, J. Thakar, G.S. Pryhuber, Rochester, NY, p.A6045 917 Fetal Lung Development in Rhesus Macaques Using Quantitative Diffusion MRI and Histological Biomarkers/ N.S. Higano, X. Cao, J. Guo, X. Wang, C.D. Kroenke, A.L. Filuta, J.P. Bridges, J.C. Woods, Cincinnati, OH, p.A6046 918 Surfactant Regulation by the Natriuretic Peptide Pathway: A New Mechanism for Steroid Effects/ R.M. Ryan, M. Paintlia, D. Newton, M.W. Kemp, A.H. Jobe, J.E. Baatz, Charleston, SC, p.A7460 919 ELBW Infants Who Progress to BPD Have Lower Pulmonary Expression of TGF-Beta/ M. Salton, S. Amatya, S. Rajbhandari, V. Trinh, L.A. Parton, Valhalla, NY, p.A7461 CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION D28 CLOT ME A RIVER: LATEST DEVELOPMENTS IN DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISMS AND CTEPH 9:15 a.m. - 11:15 a.m. KBHCCD Ballroom D Four (Level 3) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 Chairing: B.N. Rivera-Lebron, MD, MS, Pittsburgh, PA E.S. Klings, MD, Boston, MA G.A. Heresi, MD, Cleveland, OH S. Pugliese, MD, Philadelphia, PA 701 8-Isoprostane F2 a in Chronic Thromboembolic Pulmonary Hypertension: A Novel Biomarker?/ M. Liu, G. Lu, C. Li, J. Su, R. Jiang, R. Zhang, Shanghai, China, p.A6047 702 Extracellular Superoxide Dismutase in Chronic Thromboembolic Pulmonary Hypertension: A Novel Biomarker of Auxiliary Clinical Risk Management/ G. Lu, M. Liu, C. Li, J. Su, R. Jiang, R. Zhang, Shanghai, China, p.A6048 703 Pulmonary Artery Diameter and Association with Echocardiographic Parameters of Right Ventricular Dysfunction in Patients with Acute Pulmonary Embolism/ R. Alashram, E.-O. Essien, E. Male, S. Pettigrew, E. Carabelli, B. Heyman, M. Kumaran, C. Dass, G.S. Cohen, J.N. Panaro, R. Cobb, H. Zhao, R. Gupta, R. Bashir, G.J. Criner, P. Rali, Philadelphia, PA, p.A6049 704 CT Based Arterial and Venous Small Vessel Volume and Right Ventricular Dysfunction in Acute Submassive Pulmonary Embolism/ F.N. Rahaghi, P. Nardelli, J. Minhas, S.M. Hassan, S. Ash, G. Gonzalez, J. Ross, A. Hunsaker, G. Piazza, R. San José Estépar, G.R. Washko, R. San José Estépar, Boston, MA, p.A6050 705 Artificial Intelligence in Assessment of Acute Pulmonary Embolism on Computed Tomographic Pulmonary Angiography/ W. Liu, M. Liu, Beijing, China, p.A6051 706 Window of Opportunity: Single Photon Emission Computed Tomography Ventilation Perfusion (SPECT V/Q) for Follow Up of Patients with Acute Pulmonary Embolism (PE) and Baseline Marker for Future Chronic PE Related Complications/ E. Male, S. Pettigrew, R. Alashram, C. Dass, B. Kamat, G.J. Criner, P. Rali, S. Dadparvar, Philadelphia, PA, p.A6052 707 Decrease in Small Vessel Volume Fraction in CT Imaging Is Associated with Mortality in Submassive Pulmonary Embolus/ S.M. Hassan, F.N. Rahaghi, J. Minhas, S. Ash, P. Nardelli, G. Gonzalez, J.C. Ross, A. Hunsaker, G. Piazza, R. San José Estépar, R. San José Estépar, G.R. Washko, Boston, MA, p.A6053 708 BOVA Score Is Superior to sPESI in Identification of High Risk Pulmonary Embolism Patients/ J. DiBello, P. Khaing, E. Gupta, C. Au, T. Chengsupanimit, B.K. Awsare, M. Baram, F.M. West, G.C. Kane, Philadelphia, PA, p.A6054 709 Acute Pulmonary Embolism in Asthma Exacerbation: Characteristics and Hospital Outcomes/ B. Alzghoul, F. Amer, A. Innabi, M. Chizinga, E. Papierniak, I. Faruqi, Gainesville, FL, p.A6055 710 Acute Pulmonary Embolism in Patients with Obstructive Sleep Apnea; Frequency and Associated Mortality/ Z.I. Seckin, H. Helmi, T.J. Weister, E. Festic, Jacksonville, FL, p.A6056 711 Sex Differences in Predicting Acute Pulmonary Embolism Recurrence During the Different Follow-Up Periods/ P. Yuan, Y.-L. Yang, J.-L. Li, J. Liu, Shanghai, China, p.A6057 712 Sex-Specific Performance in Pulmonary Embolism Patients with Different Simplified PESI Score/ Y.L. Yang, P. Yuan, L. Wang, S. Gong, R. Jiang, W.H. Wu, C.J. Luo, J. Liu, J. He, L. Yuan, H. Qiu, Shanghai, China, p.A6058 713 Clinical Presentation and Outcomes of Patients with Pulmonary Embolism: Does Cancer Matter?/ C. Au, E. Gupta, P. Khaing, J. DiBello, T. Chengsupanimit, E.P. Mitchell, B.K. Awsare, M. Baram, F.M. West, G.C. Kane, Philadelphia, PA, p.A6059 714 The Efficacy of Direct Oral Anticoagulants on Residual Clot Burden in Obese and Non-Obese Patients with Massive and Submassive Pulmonary Embolism/ C. Bach, C. Wright, R.J. White, S.J. Cameron, D. Lachant, Rochester, NY, p.A6060 715 Relationship Between Timing of Anticoagulation Initiation and Clinical Outcomes in Acute Venous Thromboembolism Patients Who Received Low Molecular Weight Heparin or Direct Oral Anticoagulants/ M. Ahmad, K. Gunasekaran, S. Rehman, J. Devasahayam, Danville, PA, p.A6061 716 Change in Pulmonary Artery Pressure in Acute Pulmonary Embolism (PE) Treated with Standard Catheter-Directed Thrombolysis (CDT): Our Initial Experience/ O. Charran, A. Singh, D. Pan, J. Filopei, R. Patel, A. Friedman, R. Dreifuss, J. Salonia, D. Steiger, A. Shujaat, New York, NY, p.A6062 ATS 2019 • Dallas, TX WEDNESDAY • MAY 22 329 WEDNESDAY MORNING